169 related articles for article (PubMed ID: 32446797)
1. Use of metformin and risk of breast and colorectal cancer.
Rennert G; Rennert HS; Gronich N; Pinchev M; Gruber SB
Diabetes Res Clin Pract; 2020 Jul; 165():108232. PubMed ID: 32446797
[TBL] [Abstract][Full Text] [Related]
2. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
3. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
[No Abstract] [Full Text] [Related]
4. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
5. Metformin Treatment and Cancer Risk: Cox Regression Analysis, With Time-Dependent Covariates, of 320,000 Persons With Incident Diabetes Mellitus.
Dankner R; Agay N; Olmer L; Murad H; Keinan Boker L; Balicer RD; Freedman LS
Am J Epidemiol; 2019 Oct; 188(10):1794-1800. PubMed ID: 31269196
[TBL] [Abstract][Full Text] [Related]
6. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
[TBL] [Abstract][Full Text] [Related]
7. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
8. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality.
Xu H; Aldrich MC; Chen Q; Liu H; Peterson NB; Dai Q; Levy M; Shah A; Han X; Ruan X; Jiang M; Li Y; Julien JS; Warner J; Friedman C; Roden DM; Denny JC
J Am Med Inform Assoc; 2015 Jan; 22(1):179-91. PubMed ID: 25053577
[TBL] [Abstract][Full Text] [Related]
9. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy.
Kanadiya MK; Gohel TD; Sanaka MR; Thota PN; Shubrook JH
J Diabetes Complications; 2013; 27(5):463-6. PubMed ID: 23755906
[TBL] [Abstract][Full Text] [Related]
10. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
11. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
[TBL] [Abstract][Full Text] [Related]
12. Long-term metformin use is associated with decreased risk of breast cancer.
Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR
Diabetes Care; 2010 Jun; 33(6):1304-8. PubMed ID: 20299480
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients.
Tharakan S; Zimmerman B; Ru M; Blanter J; Cascetta K; Tiersten A
Oncology; 2020; 98(8):589-592. PubMed ID: 32182614
[TBL] [Abstract][Full Text] [Related]
14. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
[TBL] [Abstract][Full Text] [Related]
15. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
[TBL] [Abstract][Full Text] [Related]
16. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
[TBL] [Abstract][Full Text] [Related]
17. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
[TBL] [Abstract][Full Text] [Related]
18. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
[TBL] [Abstract][Full Text] [Related]
20. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.
Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP
Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
